Overview

Carboplatin in Patients With Progressive Gliomas

Status:
Completed

Trial end date:
2000-03-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of carboplatin in patients with progressive glioma.

Phase:

Phase 2

Details

Lead Sponsor:

Duke University

Treatments:

Carboplatin